Differences between ruxolitinib tablets/Jekewei and ruxolitinib

Ruxolitinib tablets/Ruxolitinib (Ruxolitinib) and ruxolitinib are essentially the same drug, with only differences in Chinese translation or trade name. Ruxolitinib is its international common name (INN), and "ruxolitinib" is its commonly used transliteration in China. It is also called "ruxolitinib" in some regions or literature. As for "Jiekewei", it is the trade name of the drug in China. Although the names are different, they all refer to the same oral JAK inhibitor.

In terms of clinical indications, ruxolitinib is mainly used for the treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease. The common feature of these diseases is that the JAK-STAT signaling pathway is abnormally active, leading to hematopoietic or immune dysfunction, and ruxolitinib can effectively control related pathological processes by precisely inhibiting JAK1 and JAK2. After using this drug, patients with myelofibrosis have seen their spleens shrink in size, and symptoms such as physical exertion and night sweats have been relieved; patients with polycythemia vera can use this drug to reduce the risk of venous thrombosis and improve hematological indicators; in graft-versus-host disease, this drug can improve the patient's survival and tolerance by regulating inflammatory factor signals.

It needs to be emphasized that although "ruxolitinib" and "ruxolitinib" are just different names, different names may appear in drug instructions, clinical guidelines and patient purchase channels. During use, patients should recognize that these names actually refer to ruxolitinib to avoid misunderstanding or duplication of medication. In international drug registration and circulation, INN "ruxolitinib" is the standard naming, while "ruxolitinib" and "ruxolitinib" are localized translation differences.

Therefore, there is no real difference between the two, except for differences in language and commercial nomenclature, which is common with many imported drugs.

Reference materials:https://www.jakavi.com/